Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas
{{output}}
Women with large uterine leiomyomas traditionally have had just one choice for therapy--abdominal hysterectomy. Recently, gonadotropin-releasing hormone (GnRH) agonist therapy has been introduced as an option to shrink tumors before surgery. When administered ... ...